AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Acosita-M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Acmedix Pharma LLP

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Acosita-M 500 Tablet

Diabeta-Duo 500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This helps prevent serious diabetic complications like vision impairment and kidney disease, and may lower heart attack or stroke risk. Diabeta-Duo 500mg may be used alone or with other diabetes treatments. Optimal results require a healthy diet and regular exercise. Dosage is tailored to individual health, blood sugar levels, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing is crucial for effectiveness; discontinue only as advised by your physician. Adherence to your doctor's diet and exercise plan is vital. Lifestyle significantly impacts diabetes control. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, especially with insulin or sulfonylurea use; learn to identify and manage this. This medication isn't for everyone. Inform your doctor of any history of liver, kidney, or heart problems, pancreatic issues, or excessive alcohol consumption before use. Pregnant or breastfeeding individuals require medical consultation. Interactions with other medications are possible; fully disclose all medications to your doctor. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Acosita-M 500 Tablet

No information provided. Therefore, no text can be rewritten.

Uses of Acosita-M 500 Tablet

Managing type 2 diabetes

Major Benefits of Acosita-M 500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Acosita-M 500mg tablets should be administered with a meal.

Common Side effects of Acosita-M 500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Acosita-M 500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Acosita-M 500 Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

How Acosita-M 500 Tablet works:

Acosita-M 500 Tablet merges sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose creation, slows intestinal glucose absorption, and improves insulin responsiveness. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Acosita-M 500 Tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Acosita-M 500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Acosita-M 500 Tablet use are likely incompatible. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Acosita-M 500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Acosita-M 500 Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Acosita-M 500 Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical advice.

What if you forget to take Acosita-M 500 Tablet :

Should you forget to take a dose of Acosita-M 500 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Acosita-M 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Acosita-M 500 Tablet

Acosita-M 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Acosita-M 500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, supplemental vitamin B12 is recommended at least annually, according to some research.
Acosita-M 500 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Acosita-M 500 Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Acosita-M 500 Tablet and alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Acosita-M 500 Tablet. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol, thus necessitating avoidance in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Acosita-M 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Acosita-M 500 Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Acosita-M 500 Tablets are contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Acosita-M 500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA when linked to metformin, like in Acosita-M 500 Tablet), is a potential side effect. This risk is heightened in individuals with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experiencing these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Acosita-M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Acosita-M 500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It enhances blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Acosita-M 500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Acosita-M 500 Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Acosita-M 500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid, is a potential side effect of Acosita-M 500 Tablet (containing metformin). Also known as MALA (Metformin-associated lactic acidosis), this rare complication necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Acosita-M 500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Acosita-M 500 Tablet
96